Radiation Oncology, Treatment Protocols
Head and Neck
Randomized Phase II/III Trial of Radiotherapy with Concurrent MEDI4736 (Durvalumab) Vs. Radiotherapy with Concurrent Cetuximab in Patients with Stage III-IVB Head and Neck Cancer with a Contraindication to Cisplatin
Site Delegation of Tasks Log required prior to registration of any patients.
HN004 is permanently closed to accrual effective September 1, 2022.